Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
9.89
-0.60 (-5.72%)
Jan 3, 2025, 4:00 PM EST - Market closed
Pharming Group Employees
Pharming Group had 382 employees as of December 31, 2023. The number of employees increased by 50 or 15.06% compared to the previous year.
Employees
382
Change (1Y)
50
Growth (1Y)
15.06%
Revenue / Employee
$748,024
Profits / Employee
-$46,657
Market Cap
660.13M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
PHAR News
- 21 days ago - Pharming announces public cash offer to the shareholders of Abliva AB - GlobeNewsWire
- 25 days ago - European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug - Benzinga
- 2 months ago - Pharming Group to participate in November investor conference - GlobeNewsWire
- 2 months ago - Pharming Group N.V. (PHAR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Pharming Group to report third quarter 2024 financial results on October 24 - GlobeNewsWire
- 3 months ago - Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation - GlobeNewsWire
- 3 months ago - Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib) - GlobeNewsWire
- 4 months ago - Pharming Group to participate in September investor conferences - GlobeNewsWire